Research Supporters Initiative Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -12.94%
(FY 2022)
- Profit 3.63%
(FY 2022)
- Ebitda 600.00%
(FY 2022)
- Net Worth 0.24%
(FY 2022)
- Total Assets 351.11%
(FY 2022)
About Research Supporters Initiative
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Selvakumara Sundararajan, Mariappan Venkatesan, and Subramanian Raja serve as directors at the Company.
- CIN/LLPIN
U31109TN2021PTC140814
- Company No.
140814
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Krishnagiri, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Research Supporters Initiative?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Selvakumara Sundararajan  | Managing Director | 19-Jan-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mariappan Venkatesan | Director | 19-Jan-2021 | Current |
| Subramanian Raja | Director | 19-Jan-2021 | Current |
Financial Performance of Research Supporters Initiative.
Research Supporters Initiative Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.94% decrease. The company also saw a slight improvement in profitability, with a 3.63% increase in profit. The company's net worth moved up by a moderate rise of 0.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Research Supporters Initiative?
In 2023, Research Supporters Initiative had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Research Supporters Initiative?
Research Supporters Initiative has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Research Supporters Initiative, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Research Supporters Initiative's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
